Immunotherapy Track 5: Social Consequences and Evidence Based Medicine and Immunotherapy

Saturday, 14 December 2013: 10:00 - 11:30
Great Lakes Grand Ballroom West (Westin - Michigan Avenue)
Chairpersons:   Linda Cox (United States), Giovanni Passalacqua (Italy)
10:00 - 10:05
Welcoming Remarks
10:05 - 10:25
2-10: The Consolidated Standards of Reporting Trials (CONSORT) Statement Applied to Allergen-Specific Immunotherapy with Inhalant Allergens | Jan Brozek (Canada)
10:25 - 10:45
2-11: Pharmacoeconomics of Immunotherapy | Cheryl Hankin (United States)
10:45 - 11:05
2-12: Selection of Patients for Sublingual versus Subcutaneous Immunotherapy | Désirée Larenas-Linnemann (Mexico)
• Poster AAAAI 2013 DLarenas.pdf
• EAACI 2013 poster IT and Cancer DLarenas.pdf
• Rank AAAAI poster 2013.pdf
• WAO_2013_hand-out_Selection_of_Patients_for_sublingual_versus_Subcutaneous_Immunotherapy.pdf
11:05 - 11:30
Discussion
See more of: Immunotherapy Track
<< Previous Session | Next Session >>